Search Orphan Drug Designations and Approvals
-
| Generic Name: | (R)-6-((3,3-difluoro-1-methylpiperidine-4-yl)oxy-N-(3-ethynyl-2-fluorophenyl)-7-methoxyquinazolin-4-amine-,fumerate (2:1) (salt) |
|---|---|
| Date Designated: | 07/24/2019 |
| Orphan Designation: | Treatment of glioma (including glioblastoma and anaplastic astrocytoma) |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Wayshine Biopharm Inc. 957 Ferndale Dr, Corona, California 92881 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







